Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Veterinary Autoimmune Disease Therapeutics Market Report 2024

Veterinary Autoimmune Disease Therapeutics Global Market Report 2024 – By Therapy Type (Corticosteroids, Azathioprine, Cyclosporine, Mycophenolate, Leflunomide, Cyclophosphamide, Levothyroxine, Folic Acid, Hydroxychloroquine, Chloroquine), By Animal Type (Companion Animals, Livestock Animals, Other Animals), By Disease (Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Hemolytic Anemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Immune-Related Arthritis, Other Diseases), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics) – Market Size, Trends, And Global Forecast 2024-2033

Veterinary Autoimmune Disease Therapeutics Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : July 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Veterinary Autoimmune Disease Therapeutics Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Veterinary Autoimmune Disease Therapeutics Market Definition

Veterinary autoimmune disease therapeutics refer to treatments designed to manage and alleviate animal autoimmune diseases. These therapeutics aim to modulate or suppress the immune response to reduce inflammation, prevent further tissue damage, and improve the affected animal's overall health and quality of life. Veterinary autoimmune disease therapeutics are critical for managing these complex conditions and require a tailored approach based on the specific disease, the severity of the condition, and the individual animal's needs.

The main therapy types of veterinary autoimmune disease therapeutics are corticosteroids, azathioprine, cyclosporine, mycophenolate, leflunomide, cyclophosphamide, levothyroxine, folic acid, hydroxychloroquine, and chloroquine. Corticosteroids refer to a class of steroid hormones produced in the adrenal cortex. They are often used in medicine to reduce inflammation and suppress the immune system. For animals such as companion animals, livestock animals, and others with disease-type hypothyroidism, pemphigus disease, canine lupus, autoimmune Hemolytic anemia, bullous pemphigoid, discoid lupus erythematosus (DLE), immune-related arthritis, and others. It is distributed through veterinary hospitals and veterinary clinics.

Veterinary Autoimmune Disease Therapeutics Market Segmentation

The veterinary autoimmune disease therapeutics market covered in this report is segmented –

1) By Therapy Type: Corticosteroids, Azathioprine, Cyclosporine, Mycophenolate, Leflunomide, Cyclophosphamide, Levothyroxine, Folic Acid, Hydroxychloroquine, Chloroquine

2) By Animal Type: Companion Animals, Livestock Animals, Other Animals

3) By Disease: Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Haemolytic Anaemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Immune-Related Arthritis, Other Diseases

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics

Global Veterinary Autoimmune Disease Therapeutics Market Size 2023 to 2028: Graph

Veterinary Autoimmune Disease Therapeutics Market Size 2024 And Growth Rate

The veterinary autoimmune disease therapeutics market size has grown strongly in recent years. It will grow from $3.05 billion in 2023 to $3.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to advances in immunology, increased pet ownership, improved diagnostic methods, development of new drug classes, and rising awareness of pet health.

Veterinary Autoimmune Disease Therapeutics Market Growth Forecast

The veterinary autoimmune disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.20 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to advancements in biotechnology, growing investment in veterinary healthcare, increasing prevalence of autoimmune diseases in pets, development of novel therapeutics, and rising pet insurance adoption. Major trends in the forecast period include personalized medicine, the use of biologics, the integration of telemedicine, adoption of regenerative therapies, and focus on holistic and integrative treatments personalized medicine, use of biologics, integration of telemedicine, adoption of regenerative therapies, and focus on holistic and integrative treatments.

Veterinary Autoimmune Disease Therapeutics Market Driver: Increased Funding Propels Growth In Veterinary Research And Autoimmune Disease Treatments

The increasing funding for research in veterinary medicine is expected to propel the growth of the veterinary autoimmune disease therapeutics market going forward. Veterinary medicine is the branch of medicine that deals with the prevention, diagnosis, and treatment of diseases, disorders, and injuries in animals. The increased funding for research in veterinary medicine can be attributed to rising zoonotic diseases, the growing pet industry, advances in animal health technology, agricultural demands, and wildlife conservation efforts. Funding for research in veterinary autoimmune disease supports studies on disease mechanisms, diagnostic tools, and treatment options, enhancing veterinary medicine's ability to diagnose and manage these conditions effectively. For instance, in August 2024, according to the National Institute of Food and Agriculture, a US-based department of agriculture announced 20 the Veterinary Service Grants Program (VSGP) with NIFA for investing $3.2 million in rural food animal veterinary medicine in the fiscal year 2022, across the United States. Therefore, the increased funding for research in veterinary medicine is driving the growth of the veterinary autoimmune disease therapeutics market.

Global Veterinary Autoimmune Disease Therapeutics Market Major Players

Major companies operating in the veterinary autoimmune disease therapeutics market are Pfizer Inc, Merck & Co Inc, AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline, Takeda Pharmaceutical Company, Amgen Inc., Teva Pharmaceuticals Industries Ltd., Zoetis Inc, Boehringer Ingelheim International GmbH, Sumitomo Pharma Co. Ltd., IDEXX Laboratories Inc., Cipla Inc., Mallinckrodt Pharmaceuticals, Virbac S.A, Dechra Pharmaceuticals plc, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Heska Corporation, Bimeda Holdings PLC, Bayer Animal Health Inc, Aratana Therapeutics Inc, Hester Biosciences Limited

Global Veterinary Autoimmune Disease Therapeutics Market Trend: Innovations In Canine Autoimmune Disease Research And Treatment

Major companies operating in the veterinary autoimmune disease therapeutics market are focused on developing autoimmune disease research projects to advance treatment options and improve animal health outcomes. Autoimmune disease research projects help therapeutics by uncovering disease mechanisms, leading to the development of more effective and targeted treatments. For instance, in November 2021, Royal Veterinary College, a UK-based institution of veterinary medicine, launched the ImmunoRegistry, a comprehensive research project aimed at improving the understanding and management of autoimmune diseases in dogs. The project involves an observational registry that collects real-time data on dogs diagnosed with autoimmune diseases over one year after diagnosis. The goal is to gather detailed information about the progression of these diseases and the effectiveness of treatments in various breeds of dogs. The registry focuses on four specific autoimmune diseases in dogs such as immune-mediated hemolytic anemia (IMHA), immune thrombocytopenia (ITP), immune-mediated polyarthritis (IMPA), and steroid-responsive meningitis arteritis (SRMA).

Veterinary Autoimmune Disease Therapeutics Market Merger And Acquisition: Merk & Co. Inc.'s Acquisition Of Pandion Therapeutics Inc Advances Autoimmune Disease Treatments

In February 2021, Merk & Co. Inc., a US-based pharmaceutical company in innovative research and development in healthcare solutions, acquired Pandion Therapeutics Inc for an undisclosed amount. With this acquisition, Merck aims to identify and develop candidates with unique and potentially fundamental traits. Pandion Therapeutics Inc. is a US-based biopharmaceutical company advancing novel therapies for veterinary autoimmune diseases.

Regional Insights For The Global Veterinary Autoimmune Disease Therapeutics Market

North America was the largest region in the veterinary autoimmune disease therapeutics market in 2023. The regions covered in the veterinary autoimmune disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary autoimmune disease therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary autoimmune disease therapeutics market consists of revenues earned by entities by providing immunosuppressive medications, biologic therapies, supportive therapies and complementary therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary autoimmune disease therapeutics market also includes sales of prednisone, mycophenolate mofetil, and methotrexate. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The veterinary autoimmune disease therapeutics research report is one of a series of new reports from The Business Research Company that provides veterinary autoimmune disease therapeutics market statistics, including the veterinary autoimmune disease therapeutics industry's global market size, regional shares, competitors with a veterinary autoimmune disease therapeutics market share, detailed veterinary autoimmune disease therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary autoimmune disease therapeutics industry. This veterinary autoimmune disease therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Veterinary Autoimmune Disease Therapeutics Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $3.25 billion
Revenue Forecast In 2033 $4.2 billion
Growth Rate CAGR of 6.7% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Therapy Type: Corticosteroids, Azathioprine, Cyclosporine, Mycophenolate, Leflunomide, Cyclophosphamide, Levothyroxine, Folic Acid, Hydroxychloroquine, Chloroquine
2) By Animal Type: Companion Animals, Livestock Animals, Other Animals
3) By Disease: Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Hemolytic Anemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Immune-Related Arthritis, Other Diseases
4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc, Merck & Co Inc, AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline, Takeda Pharmaceutical Company, Amgen Inc., Teva Pharmaceuticals Industries Ltd., Zoetis Inc, Boehringer Ingelheim International GmbH, Sumitomo Pharma Co. Ltd., IDEXX Laboratories Inc., Cipla Inc., Mallinckrodt Pharmaceuticals, Virbac S.A, Dechra Pharmaceuticals plc, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Heska Corporation, Bimeda Holdings PLC, Bayer Animal Health Inc, Aratana Therapeutics Inc, Hester Biosciences Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Veterinary Autoimmune Disease Therapeutics Market Characteristics

    3. Veterinary Autoimmune Disease Therapeutics Market Trends And Strategies

    4. Veterinary Autoimmune Disease Therapeutics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Veterinary Autoimmune Disease Therapeutics Market Size and Growth

    5.1. Global Veterinary Autoimmune Disease Therapeutics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Veterinary Autoimmune Disease Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Veterinary Autoimmune Disease Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Veterinary Autoimmune Disease Therapeutics Market Segmentation

    6.1. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Corticosteroids

    Azathioprine

    Cyclosporine

    Mycophenolate

    Leflunomide

    Cyclophosphamide

    Levothyroxine

    Folic Acid

    Hydroxychloroquine

    Chloroquine

    6.2. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Companion Animals

    Livestock Animals

    Other Animals

    6.3. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hypothyroidism

    Pemphigus Disease

    Canine Lupus

    Auto-Immune Hemolytic Anemia

    Bullous Pemphigoid

    Discoid Lupus Erythematosus (DLE)

    Immune-Related Arthritis

    Other Diseases

    6.4. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Veterinary Hospitals

    Veterinary Clinics

    7. Veterinary Autoimmune Disease Therapeutics Market Regional And Country Analysis

    7.1. Global Veterinary Autoimmune Disease Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Veterinary Autoimmune Disease Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market

    8.1. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Veterinary Autoimmune Disease Therapeutics Market

    9.1. China Veterinary Autoimmune Disease Therapeutics Market Overview

    9.2. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Veterinary Autoimmune Disease Therapeutics Market

    10.1. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Veterinary Autoimmune Disease Therapeutics Market

    11.1. Japan Veterinary Autoimmune Disease Therapeutics Market Overview

    11.2. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Veterinary Autoimmune Disease Therapeutics Market

    12.1. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Veterinary Autoimmune Disease Therapeutics Market

    13.1. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Veterinary Autoimmune Disease Therapeutics Market

    14.1. South Korea Veterinary Autoimmune Disease Therapeutics Market Overview

    14.2. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Veterinary Autoimmune Disease Therapeutics Market

    15.1. Western Europe Veterinary Autoimmune Disease Therapeutics Market Overview

    15.2. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Veterinary Autoimmune Disease Therapeutics Market

    16.1. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Veterinary Autoimmune Disease Therapeutics Market

    17.1. Germany Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Veterinary Autoimmune Disease Therapeutics Market

    18.1. France Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Veterinary Autoimmune Disease Therapeutics Market

    19.1. Italy Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Veterinary Autoimmune Disease Therapeutics Market

    20.1. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market

    21.1. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market Overview

    21.2. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Veterinary Autoimmune Disease Therapeutics Market

    22.1. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Veterinary Autoimmune Disease Therapeutics Market

    23.1. North America Veterinary Autoimmune Disease Therapeutics Market Overview

    23.2. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Veterinary Autoimmune Disease Therapeutics Market

    24.1. USA Veterinary Autoimmune Disease Therapeutics Market Overview

    24.2. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Veterinary Autoimmune Disease Therapeutics Market

    25.1. Canada Veterinary Autoimmune Disease Therapeutics Market Overview

    25.2. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Veterinary Autoimmune Disease Therapeutics Market

    26.1. South America Veterinary Autoimmune Disease Therapeutics Market Overview

    26.2. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Veterinary Autoimmune Disease Therapeutics Market

    27.1. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Veterinary Autoimmune Disease Therapeutics Market

    28.1. Middle East Veterinary Autoimmune Disease Therapeutics Market Overview

    28.2. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Veterinary Autoimmune Disease Therapeutics Market

    29.1. Africa Veterinary Autoimmune Disease Therapeutics Market Overview

    29.2. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Veterinary Autoimmune Disease Therapeutics Market Competitive Landscape And Company Profiles

    30.1. Veterinary Autoimmune Disease Therapeutics Market Competitive Landscape

    30.2. Veterinary Autoimmune Disease Therapeutics Market Company Profiles

    30.2.1. Pfizer Inc

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Merck & Co Inc

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. AbbVie Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Sanofi S.A.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Novartis AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Veterinary Autoimmune Disease Therapeutics Market Other Major And Innovative Companies

    31.1. GlaxoSmithKline

    31.2. Takeda Pharmaceutical Company

    31.3. Amgen Inc.

    31.4. Teva Pharmaceuticals Industries Ltd.

    31.5. Zoetis Inc

    31.6. Boehringer Ingelheim International GmbH

    31.7. Sumitomo Pharma Co. Ltd.

    31.8. IDEXX Laboratories Inc.

    31.9. Cipla Inc.

    31.10. Mallinckrodt Pharmaceuticals

    31.11. Virbac S.A

    31.12. Dechra Pharmaceuticals plc

    31.13. Neogen Corporation

    31.14. Vetoquinol S.A.

    31.15. Norbrook Laboratories Limited

    32. Global Veterinary Autoimmune Disease Therapeutics Market Competitive Benchmarking

    33. Global Veterinary Autoimmune Disease Therapeutics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Veterinary Autoimmune Disease Therapeutics Market

    35. Veterinary Autoimmune Disease Therapeutics Market Future Outlook and Potential Analysis

    35.1 Veterinary Autoimmune Disease Therapeutics Market In 2028 - Countries Offering Most New Opportunities

    35.2 Veterinary Autoimmune Disease Therapeutics Market In 2028 - Segments Offering Most New Opportunities

    35.3 Veterinary Autoimmune Disease Therapeutics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Veterinary Autoimmune Disease Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Veterinary Autoimmune Disease Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc Financial Performance
  • Table 76: Merck & Co Inc Financial Performance
  • Table 77: AbbVie Inc. Financial Performance
  • Table 78: Sanofi S.A. Financial Performance
  • Table 79: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Veterinary Autoimmune Disease Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Veterinary Autoimmune Disease Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc Financial Performance
  • Figure 76: Merck & Co Inc Financial Performance
  • Figure 77: AbbVie Inc. Financial Performance
  • Figure 78: Sanofi S.A. Financial Performance
  • Figure 79: Novartis AG Financial Performance

The Business Research Company offers the cattle feed and feed additives market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the companion animal veterinary vaccines market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the veterinary vaccines market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the veterinary pharmaceuticals market research report 2022 with industry size, share, segments and market growth

Read More

The Hand-Held Chemical And Metal Detector Market Share, Market Size, And Growth Rate 2022

Read More

The Oleochemicals Market Share, Market Size, And Growth Rate 2022

Read More

Global Cattle Feed And Feed Additives Market 2022 – Market Opportunities And Strategies

Read More

Latest Equine Healthcare Market Growth Study 2022-2026 By The Business Research Company

Read More

EdTech And Smart Classrooms Global Market Report 2024 – By Education System (Learning Management Systems, Student Information And Administration Systems, Student Collaboration Systems, Student Response Systems, Learning And Gamification, Test Preparation, Document Management Systems, Classroom Management Systems, Talent Management Systems), By Deployment (Cloud, On-Premises), By Hardware (Interactive Displays, Interactive Projectors), By Component (Hardware, Software And Services), By End Use (K-12, Higher Education, Kindergarten) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Insurance Analytics Global Market Report 2024 – By Component (Solution, Service), By Deployment Model (On premises, Cloud), By Enterprise Size (Large Enterprises, Small And Medium Enterprises (SMEs)), By Application (Claims Management, Risk Management, Customer Management And Personalization, Process Optimization, Other Applications), By End User (Insurance Companies, Government Agencies, Third Party Administrators, Brokers And Consultancies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Mobile And Wireless Backhaul Global Market Report 2024 – By Component (Equipment, Services), By Network Technology (3G And 2G, 4G, 5G), By Application (Financial Services, Medical, Retail, Media, Government, Communication, Public Utilities, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Neuroscience Antibodies & Assays Global Market Report 2024 – By Product (Consumables, Instruments ), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies ), By Application (In Vitro Diagnostics, Research, Drug Discovery ), By End User (Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Space Situational Awareness Global Market Report 2024 – By Solution (Service, Payload Systems, Software), By Capability (Detect, Track, And Identify (D/T/Id), Threat Warning And Assessment, Characterization), By Object (Mission-Related Debris, Rocket Bodies, Fragmentation Debris, Functional Spacecraft, Non-Functional Spacecraft, Other Objects), By Orbital Range (Near-Earth, Deep Space), By End Use (Commercial, Government And Military) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the veterinary autoimmune disease therapeutics market?

Veterinary autoimmune disease therapeutics refer to treatments designed to manage and alleviate animal autoimmune diseases. These therapeutics aim to modulate or suppress the immune response to reduce inflammation, prevent further tissue damage, and improve the affected animal's overall health and quality of life. Veterinary autoimmune disease therapeutics are critical for managing these complex conditions and require a tailored approach based on the specific disease, the severity of the condition, and the individual animal's needs. For further insights on the veterinary autoimmune disease therapeutics market, request a sample here

How will the veterinary autoimmune disease therapeutics market drivers and restraints affect the veterinary autoimmune disease therapeutics market dynamics? What forces will shape the veterinary autoimmune disease therapeutics industry going forward?

The veterinary autoimmune disease therapeutics market major growth driver - Increased Funding Propels Growth In Veterinary Research And Autoimmune Disease Treatments. For further insights on the veterinary autoimmune disease therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the veterinary autoimmune disease therapeutics market?

The veterinary autoimmune disease therapeutics market size has grown strongly in recent years. It will grow from $3.05 billion in 2023 to $3.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to advances in immunology, increased pet ownership, improved diagnostic methods, development of new drug classes, and rising awareness of pet health. The veterinary autoimmune disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.20 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to advancements in biotechnology, growing investment in veterinary healthcare, increasing prevalence of autoimmune diseases in pets, development of novel therapeutics, and rising pet insurance adoption. Major trends in the forecast period include personalized medicine, the use of biologics, the integration of telemedicine, adoption of regenerative therapies, and focus on holistic and integrative treatments personalized medicine, use of biologics, integration of telemedicine, adoption of regenerative therapies, and focus on holistic and integrative treatments. For further insights on the veterinary autoimmune disease therapeutics market, request a sample here

How is the veterinary autoimmune disease therapeutics market segmented?

The veterinary autoimmune disease therapeutics market is segmented
1) By Therapy Type: Corticosteroids, Azathioprine, Cyclosporine, Mycophenolate, Leflunomide, Cyclophosphamide, Levothyroxine, Folic Acid, Hydroxychloroquine, Chloroquine
2) By Animal Type: Companion Animals, Livestock Animals, Other Animals
3) By Disease: Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Haemolytic Anaemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Immune-Related Arthritis, Other Diseases
4) By Distribution Channel: Veterinary Hospitals, Veterinary ClinicsFor further insights on the veterinary autoimmune disease therapeutics market, request a sample here

Which region has the largest share of the veterinary autoimmune disease therapeutics market? What are the other regions covered in the report?

North America was the largest region in the veterinary autoimmune disease therapeutics market in 2023. The regions covered in the veterinary autoimmune disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the veterinary autoimmune disease therapeutics market, request a sample here.

Who are the major players in the veterinary autoimmune disease therapeutics market?

Major companies operating in the veterinary autoimmune disease therapeutics market are Pfizer Inc, Merck & Co Inc, AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline, Takeda Pharmaceutical Company, Amgen Inc., Teva Pharmaceuticals Industries Ltd., Zoetis Inc, Boehringer Ingelheim International GmbH, Sumitomo Pharma Co. Ltd., IDEXX Laboratories Inc., Cipla Inc., Mallinckrodt Pharmaceuticals, Virbac S.A, Dechra Pharmaceuticals plc, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Heska Corporation, Bimeda Holdings PLC, Bayer Animal Health Inc, Aratana Therapeutics Inc, Hester Biosciences Limited For further insights on the veterinary autoimmune disease therapeutics market, request a sample here.

What are the key trends in the veterinary autoimmune disease therapeutics market?

Major trend in the veterinary autoimmune disease therapeutics market - Innovations In Canine Autoimmune Disease Research And Treatment. For further insights on the veterinary autoimmune disease therapeutics market, request a sample here.

What are the major opportunities in the veterinary autoimmune disease therapeutics market? What are the strategies for the veterinary autoimmune disease therapeutics market?

For detailed insights on the major opportunities and strategies in the veterinary autoimmune disease therapeutics market, request a sample here.

How does the veterinary autoimmune disease therapeutics market relate to the overall economy and other similar markets?

For detailed insights on veterinary autoimmune disease therapeutics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the veterinary autoimmune disease therapeutics industry?

For detailed insights on the mergers and acquisitions in the veterinary autoimmune disease therapeutics industry, request a sample here.

What are the key dynamics influencing the veterinary autoimmune disease therapeutics market growth? SWOT analysis of the veterinary autoimmune disease therapeutics market.

For detailed insights on the key dynamics influencing the veterinary autoimmune disease therapeutics market growth and SWOT analysis of the veterinary autoimmune disease therapeutics industry, request a sample here.